Extensive mesenteric vein and portal vein thrombosis successfully treated by thrombolysis and anticoagulation

被引:38
作者
Tateishi, A
Mitsui, H
Oki, T
Morishita, J
Maekawa, H
Yahagi, N
Maruyama, T
Ishinose, M
Ohnishi, S
Shiratori, Y
Minami, M
Koutetsu, S
Hori, N
Watanabe, T
Nagawa, H
Omata, M
机构
[1] Univ Tokyo, Dept Gastroenterol, Bunkyo Ku, Tokyo 1138655, Japan
[2] Univ Tokyo, Dept Radiol, Tokyo 1138655, Japan
[3] Univ Tokyo, Dept Surg Oncol, Tokyo 1138655, Japan
关键词
Down syndrome; mesenteric vein; portal vein; protein S deficiency; venous thrombosis;
D O I
10.1046/j.1440-1746.2001.02557.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Mesenteric vein thrombosis is generally difficult to diagnose and can be fatal. A case of extensive thrombosis of the mesenteric and portal veins was diagnosed early and successfully treated in a 26-year-old man with Down syndrome who was admitted to hospital because of abdominal pain, severe nausea and high fever. Ultrasonography revealed moderate ascites, and there was minimal flow in the portal vein (PV) on the Doppler examination. Computed tomography (CT) showed remarkable thickening of the walls of the small intestine and extensive thrombosis of the mesenteric, portal and splenic veins. Because neither intestinal infarction nor peritonitis was seen, combined thrombolysis and anticoagulation therapy without surgical treatment was chosen. Urokinase was administered intravenously and later through a catheter in the superior mesenteric artery. Heparin and antibiotics were given concomitantly. The patient's symptoms and clinical data improved gradually. After 10 days, CT revealed that collateral veins had developed and the thrombi in the distal portions of the mesenteric veins had dissolved, although the main trunk of the PV had not recanalized. The only risk factor of thrombosis that was detected was decreased protein S activity. (C) 2001 Blackwell Science Asia Pty Ltd.
引用
收藏
页码:1429 / 1433
页数:5
相关论文
共 17 条
[1]   FIBRINOLYTIC THERAPY FOR PORTAL-VEIN THROMBOSIS [J].
BIZOLLON, T ;
BISSUEL, F ;
DETRY, L ;
TREPO, C .
LANCET, 1991, 337 (8754) :1416-1416
[2]   Recent portal or mesenteric venous thrombosis: Increased recognition and frequent recanalization on anticoagulant therapy [J].
Condat, B ;
Pessione, F ;
Denninger, MH ;
Hillaire, S ;
Valla, D .
HEPATOLOGY, 2000, 32 (03) :466-470
[3]   Cause of portal or hepatic venous thrombosis in adults:: The role of multiple concurrent factors [J].
Denninger, MH ;
Chaït, Y ;
Casadevall, N ;
Hillaire, S ;
Guillin, MC ;
Bezeaud, A ;
Erlinger, S ;
Briere, J ;
Valla, D .
HEPATOLOGY, 2000, 31 (03) :587-591
[4]  
Ho CH, 2000, AM J HEMATOL, V63, P74, DOI 10.1002/(SICI)1096-8652(200002)63:2<74::AID-AJH3>3.0.CO
[5]  
2-V
[6]   Mesenteric and portal vein thrombosis in a young patient with protein S deficiency treated with urokinase via the superior mesenteric artery [J].
Ludwig, DJ ;
Hauptmann, E ;
Rosoff, L ;
Neuzil, D .
JOURNAL OF VASCULAR SURGERY, 1999, 30 (03) :551-554
[7]   PORTAL THROMBOSIS - DYNAMIC CT FEATURES AND COURSE [J].
MATHIEU, D ;
VASILE, N ;
GRENIER, P .
RADIOLOGY, 1985, 154 (03) :737-741
[8]   The prothrombin gene G20210A mutation is not found among Japanese patients with deep vein thrombosis and healthy individuals [J].
Miyata, T ;
Kawasaki, T ;
Fujimura, H ;
Uchida, K ;
Tsushima, M ;
Kato, H .
BLOOD COAGULATION & FIBRINOLYSIS, 1998, 9 (05) :451-452
[9]  
MIYAZAKI Y, 1995, AM J GASTROENTEROL, V90, P1533
[10]   Mesenteric venous thrombosis treated with urokinase via the superior mesenteric artery [J].
Poplausky, MR ;
Kaufman, JA ;
Geller, SC ;
Waltman, AC .
GASTROENTEROLOGY, 1996, 110 (05) :1633-1635